To test this hypothesis, CD4+ and CD8+ T-cell reactivity towards these seven human cMSAg was determined for TCL of MS patients (n = 14) carrying the three MS-associated HLA risk alleles (Online Resource 1). The gene discussed is CD8A; the disease is myeloid sarcoma.